The global non-invasive prenatal testing market is currently witnessing strong growth. Non-invasive prenatal testing (NIPT) is a form of prenatal screening conducted on a pregnant woman’s blood sample to detect the presence of fetal abnormalities. The test is primarily used to diagnose genetic disorders such as Down syndrome (or trisomy 21), Edwards syndrome (or trisomy 18), Patau syndrome (or trisomy 13) and Turner syndrome, by analyzing DNA fragments in the mother’s blood. The procedure eliminates the need for various precarious and invasive procedures, such as chorionic villus sampling (CVS) and can be performed after nine weeks of pregnancy.
The growing prevalence of genetic disorders of the fetus is one of the key factors driving the market growth. Furthermore, technological advancements in the field of life sciences and healthcare industry is also providing a boost to the market. For instance, the development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have created immense possibilities to combat the chances of any serious disease at the primitive stage itself. Additionally, the increasing acceptance rate for prenatal testing, along with rising health consciousness and awareness regarding the benefits and significance of such testing among the masses, is also driving the market growth. Healthcare providers, as well as expecting parents, are adopting alternatives to diagnose other genetic disorders, including spina bifida, cleft palate, and sickle cell anemia, and treat them in the early stages of fetal development. Moreover, the shifting trend toward childbearing at high maternal age (35 years or older) is also positively impacting the market growth. Advancing maternal age can lead to numerous health complications, such as high blood pressure, reduced fertility, risk of miscarriage and increased risk of chromosomal anomalies in the fetus. Looking forward, IMARC Group expects the market to register a CAGR of around 12% during 2020-2025.
Breakup by Product Type:
Breakup by Test Type:
- Materni 21
- Harmony
- Panaroma
- Verifi
- NIFTY
- Others
Breakup by Technology:
Breakup by Test Type:
- Ultrasound Detection
- Biochemical Screening Tests
- Cell-Free DNA in Maternal Plasma Tests
- Fetal Cells in Maternal Blood Tests
- Others
Breakup by Application:
- Trisomy
- Microdeletions Syndrome
- Others
Breakup by End-User:
- Hospitals
- Diagnostic Laboratories
- Others
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Berry Genetics Inc., BGI Genomics Co. Ltd., Eurofins LifeCodexx GmbH, F. Hoffmann-La Roche AG, GE Healthcare, Igenomix, Illumina Inc., Laboratory Corporation, Natera Inc., Perkinelmer Inc., Thermo Fisher Scientific Inc., Yourgene Health, etc.
Key Questions Answered in This Report:
The global non-invasive prenatal testing market was worth around US$ 3.5 Billion in 2019.
The sudden outbreak of the COVID-19 pandemic, in early 2020, has hampered the market growth due to the high risk of coronavirus contraction upon hospital visits for numerous medical procedures involved in the prenatal testing.
According to the estimates by IMARC Group, the global non-invasive prenatal testing market will exhibit moderate growth during the next five years.
The high prevalence of genetic disorders in the fetus, along with the rising health awareness towards early disease detection at a primitive stage, is primarily driving the demand for non-invasive prenatal testing.
The development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have led to emergence of advanced testing solutions, thereby representing one of the key trends in the non-invasive prenatal testing market.
On the basis of the product type, the market has been bifurcated into consumables, and instruments.
On the basis of the test type, the market has been bifurcated into ultrasound detection, biochemical screening tests, cell-free DNA in maternal plasma tests, fetal cells in maternal blood tests, and others. In this segment, ultrasound detection dominates the global market.
On the basis of the application, the market has been bifurcated into trisomy, microdeletions syndrome, and others, where trisomy holds the largest market share.
Based on the end-user, the market has been segmented into hospitals, diagnostic laboratories, and others, where diagnostic laboratories dominate the global market.
Region-wise, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Based on region, North America currently accounts for the largest market share.
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Non-Invasive Prenatal Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Forecast
6 Market Breakup by Product Type
6.1 Consumables
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Test Type
7.1 Materni 21
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Harmony
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Panaroma
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Verifi
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 NIFTY
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Technology
8.1 NGS
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 WGS
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Method
9.1 Ultrasound Detection
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Biochemical Screening Tests
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Cell-Free DNA in Maternal Plasma Tests
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Fetal Cells in Maternal Blood Tests
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Other Tests
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Application
10.1 Trisomy
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Microdeletion Syndrome
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by End-User
11.1 Hospitals
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Diagnostic Laboratories
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Others
11.3.1 Market Trends
11.3.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Agilent Technologies, Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Berry Genetics, Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 BGI Genomics Co., Ltd.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Eurofins LifeCodexx GmbH
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.5 F. Hoffmann-La Roche AG
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.4 SWOT Analysis
16.3.6 GE Medical Systems
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Igenomix
16.3.7.1 Company. Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.8 Illumina, Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Laboratory Corporation
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Natera, Inc.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.11 Perkinelmer, Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
16.3.12 Thermo Fisher Scientific Inc.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
16.3.13 Yourgene Health
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
List of Figures
Figure 1: Global: Non-Invasive Prenatal Testing Market: Major Drivers and Challenges
Figure 2: Global: Non-Invasive Prenatal Testing Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Non-Invasive Prenatal Testing Market: Breakup by Product Type (in %), 2019
Figure 4: Global: Non-Invasive Prenatal Testing Market: Breakup by Test Type (in %), 2019
Figure 5: Global: Non-Invasive Prenatal Testing Market: Breakup by Technology (in %), 2019
Figure 6: Global: Non-Invasive Prenatal Testing Market: Breakup by Method (in %), 2019
Figure 7: Global: Non-Invasive Prenatal Testing Market: Breakup by Application (in %), 2019
Figure 8: Global: Non-Invasive Prenatal Testing Market: Breakup by End-User (in %), 2019
Figure 9: Global: Non-Invasive Prenatal Testing Market: Breakup by Region (in %), 2019
Figure 10: Global: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 11: Global: Non-Invasive Prenatal Testing (Consumables) Market: Sales Value (in Million US$), 2014 & 2019
Figure 12: Global: Non-Invasive Prenatal Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 13: Global: Non-Invasive Prenatal Testing (Instruments) Market: Sales Value (in Million US$), 2014 & 2019
Figure 14: Global: Non-Invasive Prenatal Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 15: Global: Non-Invasive Prenatal Testing (Materni 21) Market: Sales Value (in Million US$), 2014 & 2019
Figure 16: Global: Non-Invasive Prenatal Testing (Materni 21) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 17: Global: Non-Invasive Prenatal Testing (Harmony) Market: Sales Value (in Million US$), 2014 & 2019
Figure 18: Global: Non-Invasive Prenatal Testing (Harmony) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 19: Global: Non-Invasive Prenatal Testing (Panaroma) Market: Sales Value (in Million US$), 2014 & 2019
Figure 20: Global: Non-Invasive Prenatal Testing (Panaroma) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 21: Global: Non-Invasive Prenatal Testing (Verifi) Market: Sales Value (in Million US$), 2014 & 2019
Figure 22: Global: Non-Invasive Prenatal Testing (Verifi) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 23: Global: Non-Invasive Prenatal Testing (NIFTY) Market: Sales Value (in Million US$), 2014 & 2019
Figure 24: Global: Non-Invasive Prenatal Testing (NIFTY) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 25: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 26: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 27: Global: Non-Invasive Prenatal Testing (NGS) Market: Sales Value (in Million US$), 2014 & 2019
Figure 28: Global: Non-Invasive Prenatal Testing (NGS) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 29: Global: Non-Invasive Prenatal Testing (WGS) Market: Sales Value (in Million US$), 2014 & 2019
Figure 30: Global: Non-Invasive Prenatal Testing (WGS) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 31: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 32: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 33: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market: Sales Value (in Million US$), 2014 & 2019
Figure 34: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 35: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market: Sales Value (in Million US$), 2014 & 2019
Figure 36: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 37: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market: Sales Value (in Million US$), 2014 & 2019
Figure 38: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 39: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market: Sales Value (in Million US$), 2014 & 2019
Figure 40: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 41: Global: Non-Invasive Prenatal Testing (Other Tests) Market: Sales Value (in Million US$), 2014 & 2019
Figure 42: Global: Non-Invasive Prenatal Testing (Other Tests) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 43: Global: Non-Invasive Prenatal Testing (Trisomy) Market: Sales Value (in Million US$), 2014 & 2019
Figure 44: Global: Non-Invasive Prenatal Testing (Trisomy) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 45: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market: Sales Value (in Million US$), 2014 & 2019
Figure 46: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 47: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 48: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 49: Global: Non-Invasive Prenatal Testing (Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
Figure 50: Global: Non-Invasive Prenatal Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 51: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2014 & 2019
Figure 52: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 53: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 54: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 55: North America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 56: North America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 57: United States: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 58: United States: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 59: Canada: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 60: Canada: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 61: Asia Pacific: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 62: Asia Pacific: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 63: China: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 64: China: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 65: Japan: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 66: Japan: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 67: India: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 68: India: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 69: South Korea: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 70: South Korea: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 71: Australia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 72: Australia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 73: Indonesia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 74: Indonesia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 75: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 76: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 77: Europe: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 78: Europe: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 79: Germany: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 80: Germany: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 81: France: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 82: France: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 83: United Kingdom: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 84: United Kingdom: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 85: Italy: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 86: Italy: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 87: Spain: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 88: Spain: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 89: Russia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 90: Russia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 91: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 92: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 93: Latin America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 94: Latin America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 95: Brazil: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 96: Brazil: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 97: Mexico: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 98: Mexico: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 99: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 100: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 101: Middle East and Africa: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
Figure 102: Middle East and Africa: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 103: Global: Non-Invasive Prenatal Testing Industry: SWOT Analysis
Figure 104: Global: Non-Invasive Prenatal Testing Industry: Value Chain Analysis
Figure 105: Global: Non-Invasive Prenatal Testing Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Non-Invasive Prenatal Testing Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Product Type (in Million US$), 2020-2025
Table 3: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Test Type (in Million US$), 2020-2025
Table 4: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Technology Type (in Million US$), 2020-2025
Table 5: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Method (in Million US$), 2020-2025
Table 6: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Application (in Million US$), 2020-2025
Table 7: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup End-User (in Million US$), 2020-2025
Table 8: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 9: Global: Non-Invasive Prenatal Testing Market Structure
Table 10: Global: Non-Invasive Prenatal Testing Market: Key Players